These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 34108959)

  • 1. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
    Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
    Front Immunol; 2021; 12():637053. PubMed ID: 34108959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma.
    Acker G; Zollfrank J; Jelgersma C; Nieminen-Kelhä M; Kremenetskaia I; Mueller S; Ghori A; Vajkoczy P; Brandenburg S
    Eur J Cancer; 2020 Feb; 126():106-115. PubMed ID: 31927212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
    Lambertz N; El Hindy N; Kreitschmann-Andermahr I; Stein KP; Dammann P; Oezkan N; Mueller O; Sure U; Zhu Y
    BMC Cancer; 2015 Oct; 15():759. PubMed ID: 26490252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy.
    Urbantat RM; Jelgersma C; Brandenburg S; Nieminen-Kelhä M; Kremenetskaia I; Zollfrank J; Mueller S; Rubarth K; Koch A; Vajkoczy P; Acker G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function.
    Urbantat RM; Blank A; Kremenetskaia I; Vajkoczy P; Acker G; Brandenburg S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
    Angara K; Borin TF; Rashid MH; Lebedyeva I; Ara R; Lin PC; Iskander A; Bollag RJ; Achyut BR; Arbab AS
    Neoplasia; 2018 Oct; 20(10):1070-1082. PubMed ID: 30236892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
    Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
    Front Immunol; 2018; 9():2750. PubMed ID: 30542347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
    Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
    Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
    Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
    Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
    PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.
    Kuboki S; Shin T; Huber N; Eismann T; Galloway E; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
    Hepatology; 2008 Oct; 48(4):1213-23. PubMed ID: 18688883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
    Guo XD; Ji J; Xue TF; Sun YQ; Guo RB; Cheng H; Sun XL
    Front Immunol; 2020; 11():178. PubMed ID: 32194542
    [No Abstract]   [Full Text] [Related]  

  • 19. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
    Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
    J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.